IFNG and cancer: A study demonstrated that cytokine mediators and growth factors (IL-1, IL-4, IL-6, TNF-α, IFN-γ, TGF-β) regulate the control of the central nervous system in cancer patients, despite the continual loss of skeletal muscle induced by a number of processes [53,54].